v3.25.2
Loans Receivable and ACL-Loans - Schedule of Portfolio Segment and Impairment Methodology, of the ACL-Loan and Related Portfolio (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio $ 63,857   $ 113,901      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 2,605,125   2,591,987      
Loans collectively evaluated for impairment, allowance 29,256   29,007      
Portfolio 2,668,982   2,705,888      
ACL-Loans 29,256 $ 29,485 29,007 $ 36,083 $ 27,991 $ 27,946
Residential Real Estate            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 2,846   3,052      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 32,133   39,714      
Loans collectively evaluated for impairment, allowance 65   94      
Portfolio 34,978   42,766      
ACL-Loans 65 87 94 123 133 149
Commercial Real Estate            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 16,387   44,814      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 1,785,837   1,854,320      
Loans collectively evaluated for impairment, allowance 19,292   21,838      
Portfolio 1,802,224   1,899,134      
ACL-Loans 19,292 20,562 21,838 22,473 21,666 20,950
Construction            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 0   0      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 203,758   173,555      
Loans collectively evaluated for impairment, allowance 2,904   2,059      
Portfolio 203,758   173,555      
ACL-Loans 2,904 2,216 2,059 2,272 1,543 1,699
Commercial Business            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 6,871   7,672      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 552,350   507,453      
Loans collectively evaluated for impairment, allowance 5,526   4,070      
Portfolio 559,221   515,125      
ACL-Loans 5,526 5,244 4,070 10,647 4,078 4,562
Consumer            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 37,753   58,363      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 31,047   16,945      
Loans collectively evaluated for impairment, allowance 1,469   946      
Portfolio 68,801   75,308      
ACL-Loans $ 1,469 $ 1,376 $ 946 $ 568 $ 571 $ 586